Macular Degeneration: all 1,490 studies
Page 13 of 15. Open to participants first (208), then studies with results posted, then the rest; newest registration first within each.
- Intravitreal Injection Anesthesia - Comparison of Different Topical AgentsCompletedNCT01224847Not applicable
- Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)Status unknownNCT01217762Phase 1
- Genetics in Non-response to Anti-VEGF Treatment in Exudative AMDStatus unknownNCT01213667Phase 4
- A Single-Center Pilot Study to Assess Macular FunctionCompletedNCT01204541
- HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular DegenerationTerminatedNCT01189019Phase 2
- Preliminary Safety and Efficacy of the PDS-1.0 in Patients With Neovascular Age Related Macular Degeneration (AMD)CompletedNCT01186432Phase 1
- Safety and Preliminary Efficacy Study of PDS-1.0 in Patients With Neovascular AMDWithdrawnNCT01177644Phase 1
- Implication of CD35, CD21 and CD55 in Exudative Age-related Macular DegenerationStatus unknownNCT01174407
- French Evaluation Group Avastin Versus LucentisCompletedNCT01170767Phase 3
- Size Progression of Macular Degeneration After Cataract SurgeryCompletedNCT01165801Phase 4
- Comparison of Ranibizumab Monotherapy and Ranibizumab Combination Therapies in Recurrent or Persistent Choroidal Neovascularization Secondary to Age-related Macular DegenerationCompletedNCT01162746Phase 2
- A Randomized, Double-masked, Multicenter, Controlled Study of Intravitreal KH902 in Patients With Neovascular AMDCompletedNCT01157715Phase 2
- A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular DegenerationCompletedNCT01154062Phase 1
- Intravitreal Adalimumab in Patients With Choroidal Neovascularization Secondary to Age-related Macular DegenerationCompletedNCT01136252Phase 2
- LUCAS (Lucentis Compared to Avastin Study)CompletedNCT01127360Phase 4
- Early Vitrectomy for Macular Tractional MaculopathyStatus unknownNCT01121978Not applicable
- GARM II: A Study on the Genetics of Age-related MaculopathyActive, not recruitingNCT01115387
- LOC387715/HTRA1 Variants in Polypoidal Choroidal Vasculopathy in a Korean PopulationCompletedNCT01108250Not applicable
- Age-Related Macular Degeneration (AMD) - Beta Study Telemedicine AssessmentCompletedNCT01083147
- Evaluation of Optical Coherence Tomography.CompletedNCT01080898
- Comparison Between Foresee Home and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV)CompletedNCT01073592
- A Safety Study to Evaluate Pazopanib Eye Drops in Healthy VolunteersCompletedNCT01072214Phase 1
- A Safety Study in Healthy Volunteers to Evaluate Safety, How Fast the Drug is Absorbed, and the Side Effects of the Drug in HumansCompletedNCT01051700Phase 1
- Effects of Lutein and Zeaxanthin Supplementation on Age-related Macular DegenerationStatus unknownNCT01048476Phase 1/2
- The Influence of Lutein Supplements on Age-related Macular DegenerationCompletedNCT01042860Not applicable
- Phase I Study of Palomid 529 a Dual TORC1/2 Inhibitor of the PI3K/Akt/mTOR Pathway for Advanced Neovascular Age-Related Macular DegenerationCompletedNCT01033721Phase 1
- Photodynamic Therapy Alone Versus Combined With Intravitreal Bevacizumab for Age-related Macular DegenerationCompletedNCT01032109Not applicable
- Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)CompletedNCT01024998Phase 1
- Macular Function During Anti-VEGF TreatmentStatus unknownNCT01023971
- Bevacizumab Versus Ranibizumab in Age Related Macular DegenerationStatus unknownNCT01014468Phase 3
- A Pilot Study of the Safety of MC-1101 in Both Normal Volunteers and Patients With Early Dry AMDCompletedNCT01013376Phase 1
- Foresee Home for Monitoring Age Related Macular Degeneration (AMD)CompletedNCT01010997
- Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic AtrophyCompletedNCT01002950Phase 2
- Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular DegenerationStatus unknownNCT00996684Phase 2
- Macular Pigment Optical Density in Healthy SubjectsTerminatedNCT00993330
- WALTZ - Wet Age-Related Macular Degeneration (AMD) AL-39324 Treatment ExaminationCompletedNCT00992563Phase 2
- Association Between Laser Interferometric Measurement of Fundus Pulsation and Pneumotonometric Measurement of Pulsatile Ocular Blood Flow in Patients With Age-related Macular DegenerationCompletedNCT00991666Not applicable
- Omega 6:Omega 3 Ratio and Progression of Age-related Macular Degeneration (AMD).TerminatedNCT00987129
- A Long-Term Monitoring Study of the IMT-002 PatientsCompletedNCT00976235Not applicable
- Combination of Ranibizumab and Verteporfin Therapy in Neovascular Age-related Macular DegenerationCompletedNCT00967213Phase 3
- Age-Related Macular Degeneration (AMD) - Usability StudyCompletedNCT00963339
- Effect of Saffron Supplementation on Macular Cone-mediated Function in Age-related Macular DegenerationStatus unknownNCT00951288Phase 1/2
- A Study of ARC1905 (Anti-C5 Aptamer) in Subjects With Dry Age-related Macular DegenerationCompletedNCT00950638Phase 1
- Toronto and Oak Ridge Photobiomodulation Study for Dry Age Related Macular DegenerationCompletedNCT00940407Phase 2
- The Spectralis-Cirrus StudyCompletedNCT00927303
- Investigating Optical and Neural Causes of Vision LossWithdrawnNCT00926913
- Posterior Macular Adhesion: A Potential Risk Factor for Non-exudative Age Related Macular Degeneration (AMD) to Develop Exudative AMDStatus unknownNCT00926861
- A Study Of Early Markers Of Choroidal NeovascularizationTerminatedNCT00902785
- Effect of Lutein-enriched-egg Beverage on Age-Related Macular Degeneration (AMD)CompletedNCT00902408Not applicable
- Supplemental Adjuvants for Intracellular Nutrition and TreatmentStatus unknownNCT00893724Not applicable
- Correlation Between Visual Field Defects on FORESEE HOME and on Optical Coherence Tomography in Choroidal Neovascularization SubjectsCompletedNCT00884637
- Effects of Lutein Supplementation on Macular Pigment Optical Density and Visual Acuity in Patients With Age-related Macular DegenerationCompletedNCT00879671Not applicable
- Retinal Thickness and Volume Estimates Given by Time Domain and Spectral Optical Coherence TomographyCompletedNCT00873106
- Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis for Ocular Hypertension Control After Intravitreal BevacizumabCompletedNCT00864838Phase 2
- Long-Term Use Of Pegaptanib In Patients For Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular DegenerationCompletedNCT00845273
- Antibiotic Resistant Patterns of Conjunctival and Nasophayngeal Flora After Repeated Exposure to Topical AntibioticsCompletedNCT00831961
- Evaluation of Safety and Efficacy of Once Monthly Ranibizumab Injections in Chinese Patients With Wet Age Related Macular Degeneration (AMD) PatientsCompletedNCT00826371Phase 3
- Efficacy, Safety, Tolerability of Pegaptanib Sodium (Macugen) in Filipino Patients With Neovascular Age Related Macular Degeneration.WithdrawnNCT00820742
- Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular DegenerationStatus unknownNCT00813891Phase 4
- Does Vascular Endothelial Growth Factor (VEGF) or Complement Factor H Gene Polymorphism Play a Role in the Treatment Success With VEGF Inhibitors in Patients With Choroidal NeoVascularization (CNV)?WithdrawnNCT00813514Not applicable
- A Study of the NeoVista Ophthalmic System for the Treatment of Subfoveal CNV Associated With Wet AMD in Patients That Require Persistent Anti-VEGF TherapyStatus unknownNCT00809419Phase 1/2
- Choroidal Blood Flow and Progression of Age-Related Macular Degeneration in the Fellow Eye in Patients With Unilateral Choroidal NeovascularisationCompletedNCT00808197Not applicable
- Combined Therapy in Age-Related Macular Degeneration (ARMD)CompletedNCT00805649Phase 4
- Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular DegenerationCompletedNCT00805233Phase 2
- Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After BevacizumabCompletedNCT00804921Phase 2
- Transcorneal Electrical Stimulation Therapy for Retinal DiseaseCompletedNCT00804102Not applicable
- Characterization of Early Markers of Choroidal NeovascularizationCompletedNCT00801541
- Superoxide Dismutase (SOD) as Antioxidant Treatment OF Age Related Macular Degeneration (ARMD)CompletedNCT00800995Phase 3
- Function and Structure Imaging in Different Retinal Diseases: Retinal Leakage Analyzer Versus Optical Coherence TomographyCompletedNCT00797524
- A Prospective Study Comparing Ranibizumab Plus Dexamethasone Combination Therapy Versus Ranibizumab Monotherapy for Wet AMDCompletedNCT00793923Phase 1/2
- Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular MaculopathyCompletedNCT00791570Phase 1
- ERG/EOG Study in AMD Patients Treated With RanibizumabCompletedNCT00791427
- Subretinal Macugen® for Neovascular Age-Related Macular DegenerationStatus unknownNCT00788177Phase 3
- A Phase 1 Ascending and Parallel Group Trial to Establish the Safety, Tolerability and Pharmacokinetics Profile of Volociximab (Alpha 5 Beta 1 Integrin Antagonist) in Subjects With Neovascular Age- Related Macular DegenerationCompletedNCT00782093Phase 1
- Ocular Growth Factors Profile in Proliferative Retinopathies Before and After Intravitreal BevacizumabCompletedNCT00776763Phase 2
- Usability of the PreView PHP for Home Use in Intermediate AMD PatientsCompletedNCT00776451
- Safety Study of iSONEP (Sonepcizumab/LT1009) to Treat Neovascular Age-related Macular DegenerationStatus unknownNCT00767949Phase 1
- Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular DegenerationTerminatedNCT00766337Phase 2
- Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation on Optical Density of AMD Patients (LUTEGA)CompletedNCT00763659Not applicable
- Validation of a New Methodology for Mapping the Human Blood-Retinal Barrier FunctionCompletedNCT00759044
- Dry Age-Related Macular Degeneration (AMD) Treatment With Rheopheresis TrialCompletedNCT00751361Phase 4
- Usability of the Foresee Home in Intermediate Age Related Macular Degeneration (AMD) PatientsCompletedNCT00748384
- Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD)Status unknownNCT00745511Phase 1/2
- Assessment of Psychological Strain and Perioperative Fear in Intravitreal InjectionsCompletedNCT00734721Phase 2
- AREDS 2 Ancillary Spectral Domain Optical Coherence Tomography StudyCompletedNCT00734487
- VEGF-antagonism and Endothelial Function in Age-related Macular Degeneration (AMD)CompletedNCT00727753
- Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular DegenerationWithdrawnNCT00726466Phase 1
- Study of PF-04523655 (REDD14NP) In Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (Wet AMD)CompletedNCT00725686Phase 1
- Open Label Study for the Evaluation of Tolerability of Five Dose Levels of Cand5CompletedNCT00722384Phase 1
- Phase II Open Label Multicenter Study For Age Related Macular Degeneration Comparing PF-04523655 Versus Lucentis In The Treatment Of Subjects With CNV (MONET Study).CompletedNCT00713518Phase 2
- Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular DegenerationTerminatedNCT00712491Phase 1/2
- Manta Study: Avastin Versus Lucentis in Age Related Macular DegenerationStatus unknownNCT00710229Phase 3
- The Effect of a Single Intravitreal Anti-VEGF Therapy on Optic Nerve Head PerfusionTerminatedNCT00709657Not applicable
- ARC1905 (Anti-C5 Aptamer) Given With Lucentis 0.5 mg In People With Neovascular Age-Related Macular DegenerationCompletedNCT00709527Phase 1
- An Open Study Comparing the Effects of Moxaverine on Ocular Blood Flow in Patients With Age- Related Macular Degeneration, Primary Open Angle Glaucoma and Healthy Control SubjectsCompletedNCT00709449Phase 2/3
- Does Complement Factor H Gene Polymorphism Play a Role in the Regulation of Vascular Tone in the Choroid?CompletedNCT00708929Not applicable
- Photodynamic Therapy Combined With Bevacizumab vs Bevacizumab Alone for Neovascular Age-related Macular DegenerationWithdrawnNCT00696592Phase 2
- Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV)Status unknownNCT00695682Phase 1
- Correlation Between Visual Field Defects on Foresee Preferential Hyperacuity Perimeter(PHP) and on Optical Coherence Tomography (OCT) in Patients With Choroidal Neovascularization (CNV)CompletedNCT00692887
- Retinal Effects After Combined Photodynamic Therapy (PDT) With Intravitreal TriamcinoloneCompletedNCT00685100Phase 3